 |
Back | |
 |
Posted: November 17, 2017
Department of Transportation final rule on changes to drug-testing program
The Department of Transportation has published in the Federal Register a notice regarding changes to the DOT drug-testing program, which will take effect January 1, 2018. The DOT's summary of the final rule is as follows:The Department of Transportation is amending its drug-testing program regulation to add hydrocodone, hydromorphone, oxymorphone, and oxycodone to its drug-testing panel; add methylenedioxyamphetamine as an initial test analyte; and remove methylenedioxyethylamphetamine as a confirmatory test analyte. The revision of the drug-testing panel harmonizes DOT regulations with the revised HHS Mandatory Guidelines established by the U.S. Department of Health and Human Services for Federal drug-testing programs for urine testing. This final rule clarifies certain existing drug-testing program provisions and definitions, makes technical amendments, and removes the requirement for employers and Consortium/Third Party Administrators to submit blind specimens.
The complete text of the DOT notice in the Federal Register is available online.